Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Melanoma 14Squamous Cell Carcinoma of Head and Neck 12Colorectal Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Breast Neoplasms 10Carcinoma, Renal Cell 7Prostatic Neoplasms 6Head and Neck Neoplasms 6Diabetes Mellitus, Insulin-Dependent, 12 6Neoplasms 5Lung Neoplasms 5Biliary Tract Neoplasms 5Small Cell Lung Carcinoma 4Ovarian Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Recurrence 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Fallopian Tube Neoplasms 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Advanced Solid Tumors 3Stomach Neoplasms 2Sarcoma 2Recurrent Squamous Cell Lung Carcinoma 2Liver Neoplasms 2Kidney Neoplasms 2Gallbladder Neoplasms 2Esophageal Squamous Cell Carcinoma 2

Interventions

Doxorubicin 13Ifosfamide 10Radiotherapy 6Sunitinib 3pegfilgrastim 2Trabectedin 2Radiotherapy, Conformal 2Nivolumab 2Methotrexate 2Ipilimumab 2Imatinib Mesylate 2Filgrastim 2Etoposide 2Cisplatin 2Chemotherapy, Adjuvant 2tremelimumab 1temsirolimus 1soblidotin 1saracatinib 1romidepsin 1ribociclib 1reolysin 1perifosine 1pembrolizumab 1pazopanib 1olaratumab 1montanide ISA 51 1liposomal doxorubicin 1indolepropanol phosphate 1exatecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Histiocytoma, Malignant Fibrous × tremelimumab × Clear all
NCT02815995 2025-06-12

Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes

M.D. Anderson Cancer Center

Phase 2 Completed
57 enrolled 18 charts
Sarcoma

Hemangiosarcoma, Leiomyosarcoma, Osteosarcoma, Sarcoma, Synovial, Hemangioendothelioma, Epithelioid, Vascular Neoplasms, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡